IRX5 and gastric cancer: In a study comparing subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in the same cachectic GC patient, IRX5 was observed to be one of the top 10 upregulated DEGs, and it was also identified as a key gene in a regulatory network [112].